Akebia Therapeutics Inc. (AKBA) Shares Down Despite Recent Market Volatility
The stock price of Akebia Therapeutics Inc. (NASDAQ: AKBA) has plunged by -5.30 when compared to previous closing price of 1.32, but the company has
The stock price of Akebia Therapeutics Inc. (NASDAQ: AKBA) has plunged by -5.30 when compared to previous closing price of 1.32, but the company has
Akebia Therapeutics Inc. (NASDAQ: AKBA)’s stock price has increased by 3.53 compared to its previous closing price of 1.36. However, the company has seen a
Additionally, the 36-month beta value for AKBA is 0.88. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 0
AKBA has 36-month beta value of 0.86. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 0 as “overweight,”
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.